Safety alertFDAPublished

Rising Pharma Holdings Inc.: Cetirizine Hydrochloride Tablets USP 5 mg

Cetirizine Hydrochloride Tablets USP 5 mg. Potential cross contamination with Ranitidine.

What to check on the product label

Compare the exact product and every lot, model, serial range or date listed in the official notice. A similar name alone does not establish that your product is included.

This imported record does not provide a separate identifier list. Read the complete official notice for the affected products and restrictions.

Details to have ready

Medicine & strength: Drug name, manufacturer, dose strength and dosage form. NDC & lot: National Drug Code and batch number, where available on the original pack. Expiration & pharmacy: Expiration date and dispensing details if your prescription was repackaged.

Read the medicines identification guide

Why this notice was issued

Potential cross contamination with Ranitidine

Official action

Open the official FDA notice to confirm whether your product is included and read the current instructions from the agency and manufacturer.

Follow the specific instructions and use the contact details in the announcement if you need help confirming a match or arranging the remedy.

Read the full official instructions

Product & source details

Product
Cetirizine Hydrochloride Tablets USP 5 mg
Brand or manufacturer
Rising Pharma Holdings Inc.
Source
FDA
Notice type
Safety alert
Category
Medicines
View all